Treatment of Autoimmune Bullous Disorders in Pregnancy

Commentary on “ Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: A systematic review with meta-analysis”

(2017) SL Kanis et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?

(2017) Soheil Tavakolpour   INTERNATIONAL IMMUNOPHARMACOLOGY

Prevention and management of glucocorticoid-induced side effects: A comprehensive review

(2017) Avrom Caplan et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Updated evidence-based (S2e) European Dermatology Forum guideline on topical corticosteroids in pregnancy

(2017) C.-C. Chi et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial

(2017) Hywel C Williams et al.   LANCET

The relationship between maternal corticosteroid use and orofacial clefts-a meta-analysis

(2017) Wen-lin Xiao et al.   REPRODUCTIVE TOXICOLOGY

Lactation and Management of Postpartum Disease

(2017) Bonnie L. Bermas   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Low level of Rituximab in human breast milk in a patient treated during lactation

(2017) Yngvill Bragnes et al.   RHEUMATOLOGY

Pemphigus

(2017) Michael Kasperkiewicz et al.   Nature Reviews Disease Primers

The Efficacy and Safety of Cyclosporin A in Pregnant Patients with Systemic Autoimmune Diseases

(2016) Rossella Reggia et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

(2016) Carina Götestam Skorpen et al.   ANNALS OF THE RHEUMATIC DISEASES

Management of rheumatic and autoimmune blistering disease in pregnancy and postpartum

(2016) Joy Wan et al.   CLINICS IN DERMATOLOGY

Autoimmune bullous diseases with skin and eye involvement: Cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplastica

(2016) Karen C. Broussard et al.   CLINICS IN DERMATOLOGY

Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature

(2016) Z. Ozturk et al.   Dermatologic Therapy

Revisiting doxycycline in pregnancy and early childhood – time to rebuild its reputation?

(2016) Ruby Cross et al.   Expert Opinion On Drug Safety

Bullous pemphigoid successfully treated with omalizumab

(2016) Müzeyyen Gönül et al.   Indian Journal of Dermatology Venereology & Leprology

Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease

(2016) Christian Mottet et al.   INFLAMMATORY BOWEL DISEASES

Safety of anti-rheumatic drugs for rheumatoid arthritis in pregnancy and lactation

(2016) Gene-Siew Ngian et al.   International Journal of Rheumatic Diseases

European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology

(2016) Alexander Enk et al.   JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT

Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature

(2016) G. Balakirski et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Tetracyclines and/or nicotinamide in blistering dermatosis

(2016) A. Abdelmaksoud   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Successful monotherapy of pemphigus vegetans with minocycline and nicotinamide

(2016) A. von Köckritz et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Breastfeeding in mothers with systemic lupus erythematosus

(2016) M Noviani et al.   LUPUS

Management of Inflammatory Bowel Disease during Pregnancy and Breastfeeding Varies Widely: A Need for Further Education

(2016) Vivian Wai-Mei Huang et al.   Canadian Journal of Gastroenterology and Hepatology

Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities

(2015) Sung Ki Lee et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

IVIG therapy in pemphigus vulgaris has corticosteroid-sparing and immunomodulatory effects

(2015) Danka Svecova   AUSTRALASIAN JOURNAL OF DERMATOLOGY

Colchicine Use During Breastfeeding

(2015) Tina Herscovici et al.   Breastfeeding Medicine

A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0·5 mg kg−1 daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (B

(2015) J.R. Chalmers et al.   BRITISH JOURNAL OF DERMATOLOGY

A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone

(2015) R.P. Hall et al.   BRITISH JOURNAL OF DERMATOLOGY

Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome

(2015) Miguel Ángel Saavedra et al.   CLINICAL RHEUMATOLOGY

Pemphigus Vulgaris: An Evidence-Based Treatment Update

(2015) Cathy Y. Zhao et al.   DRUGS

Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis

(2015) Tegan Nguyen et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy

(2015) Jennifer Namazy et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Outcomes of pregnancy following liver transplantation: The King's College Hospital experience

(2015) Rachel H. Westbrook et al.   LIVER TRANSPLANTATION

Tryptophan-Immunadsorption bei Multipler Sklerose und Neuromyelitis optica

(2015) F. Hoffmann et al.   NERVENARZT

Immunosuppressive drugs and fertility

(2015) Clara Leroy et al.   Orphanet Journal of Rare Diseases

Immunoadsorption Versus Therapeutic Plasma Exchange. Will Fibrinogen Make the Difference

(2014) Patrick M. Honoré et al.   BLOOD PURIFICATION

Safety considerations when prescribing immunosuppression medication to pregnant women

(2014) Maria Gerosa et al.   Expert Opinion On Drug Safety

Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs

(2014) S Mozaffari et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

The Management of Pemphigus Vulgaris in a Burn Intensive Care Unit

(2014) Nathanial Miletta et al.   Journal of Burn Care & Research

Japanese guidelines for the management of pemphigus

(2014) et al.   JOURNAL OF DERMATOLOGY

Two decades of using the combination of tetracycline derivatives and niacinamide as steroid-sparing agents in the management of pemphigus: Defining a niche for these low toxicity agents

(2014) Morgan McCarty et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Omalizumab therapy for bullous pemphigoid

(2014) Kenneth K. Yu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Safety of dermatologic medications in pregnancy and lactation

(2014) Jenny E. Murase et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Safety of dermatologic medications in pregnancy and lactation

(2014) Daniel C. Butler et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)

(2014) M. Hertl et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Recent Changes in Pregnancy and Lactation Labeling: Retirement of Risk Categories

(2014) Leda L. Ramoz et al.   PHARMACOTHERAPY

A review of nicotinamide: treatment of skin diseases and potential side effects

(2014) Heidi M Rolfe   Journal of Cosmetic Dermatology

Pregnancy Outcome After Methotrexate Treatment for Rheumatic Disease Prior to or During Early Pregnancy: A Prospective Multicenter Cohort Study

(2014) Corinna Weber-Schoendorfer et al.   Arthritis & Rheumatology

Analysis of High-dose Intravenous Immunoglobulin Therapy in 16 Patients with Refractory Autoimmune Blistering Skin Disease: High Efficacy and No Serious Adverse Events

(2013) V Seidling et al.   ACTA DERMATO-VENEREOLOGICA

Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease

(2013) T. G. J. de Meij et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Treatment of dermatologic connective tissue disease and autoimmune blistering disorders in pregnancy

(2013) Inbal Braunstein et al.   Dermatologic Therapy

Ciclosporin Use During Pregnancy

(2013) Karolina Paziana et al.   DRUG SAFETY

Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease

(2013) Bindia Jharap et al.   GUT

Prophylaxis and Treatment of Anthrax in Pregnant Women

(2013) Dana Meaney-Delman et al.   OBSTETRICS AND GYNECOLOGY

No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study

(2013) C. Weber-Schoendorfer et al.   RHEUMATOLOGY

Toxicité rétinienne de l’hydroxychloroquine chez le nouveau-né exposé in utero

(2013) Naoual Tarfaoui et al.   THERAPIE

Risk of miscarriage among users of corticosteroid hormones: a population-based nested case-control study

(2013) Anne-Mette Bay Bjørn et al.   Clinical Epidemiology

Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services

(2012) Maria Hoeltzenbein et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART A

Successful Treatment of Bullous Pemphigoid With Omalizumab

(2012) Vanessa A. London et al.   ARCHIVES OF DERMATOLOGY

Teratogen update: Methotrexate

(2012) Sara C. Hyoun et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

British Association of Dermatologists’ guidelines for the management of bullous pemphigoid 2012

(2012) V.A. Venning et al.   BRITISH JOURNAL OF DERMATOLOGY

Therapeutic plasma exchange as a crisis option in severe pemphigus vulgaris

(2012) Rashmi Kumari et al.   Indian Journal of Dermatology Venereology & Leprology

Successful management of severe infant bullous pemphigoid with omalizumab

(2011) C. Dufour et al.   BRITISH JOURNAL OF DERMATOLOGY

Corticosteroid use during pregnancy and risk of orofacial clefts

(2011) A. Hviid et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Epidermolysis bullosa acquisita

(2011) Rishu Gupta et al.   CLINICS IN DERMATOLOGY

Management of Autoimmune Blistering Diseases in Pregnancy

(2011) Tess McPherson et al.   DERMATOLOGIC CLINICS

Glucocorticosteroid-resistant pemphigoid gestationis: Successful treatment with adjuvant immunoadsorption

(2011) Lilia WESTERMANN et al.   JOURNAL OF DERMATOLOGY

Fatal case of disseminated BCG infection after vaccination of an infant with in utero exposure to infliximab

(2011) Misha M. Heller et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus

(2011) Linda K. Martin et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Fetal Adrenal Suppression Due to Maternal Corticosteroid Use: Case Report

(2011) Selim Kurtoğlu et al.   Journal of Clinical Research in Pediatric Endocrinology

Pregnancy outcomes after maternal exposure to rituximab

(2010) E. F. Chakravarty et al.   BLOOD

The efficacy of nicotinamide gel 4% as an adjuvant therapy in the treatment of cutaneous erosions of pemphigus vulgaris

(2010) Fariba Iraji et al.   Dermatologic Therapy

Autoimmune Bullous Skin Diseases Occurring under Anti-Tumor Necrosis Factor Therapy: Two Case Reports

(2010) L. Boussemart et al.   DERMATOLOGY

Use of intravenous immunoglobulin therapy during pregnancy in patients with pemphigus vulgaris

(2010) A.R. Ahmed et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Efficacy of Dapsone in the Treatment of Pemphigus and Pemphigoid

(2009) Hakan M. Gürcan et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Immunoadsorption in the treatment of pemphigus

(2009) Alexander Mlynek et al.   ATHEROSCLEROSIS SUPPLEMENTS

Bullous Pemphigoid during Long-Term TNF-α Blocker Therapy

(2009) Matteo Bordignon et al.   DERMATOLOGY

Cyclosporine treatment of steroid-refractory ulcerative colitis during pregnancy

(2009) Julien Branche et al.   INFLAMMATORY BOWEL DISEASES

Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab

(2009) Janet A. Fairley et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

A randomized double-blind trial of intravenous immunoglobulin for pemphigus

(2009) Masayuki Amagai et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases

(2009) Kirk Sperber et al.   Pediatric Rheumatology

Do Safe and Effective Treatment Options Exist for Patients With Active Pemphigus Vulgaris Who Plan Conception and Pregnancy?

(2008) Julia S. Lehman et al.   ARCHIVES OF DERMATOLOGY

Rituximab Administration in Third Trimester of Pregnancy Suppresses Neonatal B-Cell Development

(2008) D. T. Klink et al.   Clinical & Developmental Immunology